Bristol-myers Squibb Company

FDA Drug Class II Ongoing

Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11

October 21, 2025 Bristol-myers Squibb Company 12,778 total vials units

FDA Drug Class I Terminated

EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21

June 5, 2017 Bristol-myers Squibb Company 48,180 bottles units

FDA Drug Class I Terminated

BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc. Bedford, OH 44146 Diluent manufactured by: Luitpold Pharmaceuticals, Inc. Shirley, N

August 29, 2012 Bristol-myers Squibb Company 31,481 kits units

FDA Drug Class II Terminated

Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 7 Tablets per Carton, 5 mg/500 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Prince

June 5, 2012 Bristol-myers Squibb Company N/A units

FDA Drug Class II Terminated

Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 6 Tablets per Carton, 2.5 mg/1000 mg, Rx only, Manufactured By: Bristol-Myers Squibb Company, Pri

June 5, 2012 Bristol-myers Squibb Company 117,049 Sample Cartons units